Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PositronPOSC +5.51%30 Market Cap is $57.87 Mil as of Jul. 31, 2026. GuruFocus rates POSC with a GF Score™ of 30/100 and a GF Value™ of $0.12 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 862 Medical Devices & Instruments companies, Positron ranks worse than 59.86% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Positron's share price for the quarter that ended in Dec. 2025 was $1.67. Positron's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 32.80 Mil. Therefore, Positron's market cap for the quarter that ended in Dec. 2025 was $54.77 Mil.
Positron's quarterly market cap
increased
from Dec. 2014 ($7.22 Mil) to Dec. 2024 ($27.58 Mil) and
increased
from Dec. 2024 ($27.58 Mil) to Dec. 2025 ($54.77 Mil).
Positron's annual market cap
increased
from Dec. 2014 ($7.22 Mil) to Dec. 2024 ($27.58 Mil) and
increased
from Dec. 2024 ($27.58 Mil) to Dec. 2025 ($54.77 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Positron's Enterprise Value for Today is $58.08 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Positron Market Cap Related Terms
Positron Market Cap Historical Data
* Premium members only.
The historical data trend for Positron's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Positron's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Positron Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Positron's Market Cap distribution charts can be found below:
* The bar in red indicates where Positron's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Positron's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Positron (POSC) has a Market Cap of $57.87 Mil as of Jul. 31, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Positron and its competitors. According to the industry distribution chart, Positron ranks #516 out of 862 companies in the Medical Devices & Instruments industry, placing it in the top 59.9%.
Is Positron's Market Cap too high?
Positron's current Market Cap is $57.87 Mil. The Medical Devices & Instruments industry median Market Cap is 113.83. Positron's value of $57.87 Mil is 49.2% below this industry median. Based on the distribution chart, Positron ranks #516 out of 862 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Positron has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Positron's Market Cap compare to MDAI and ECOR?
According to the Medical Devices & Instruments industry distribution chart, Positron ranks #516 out of 862 companies for Market Cap. This places Positron in the lower half of its industry. The industry median Market Cap is 113.83. Positron's value of $57.87 Mil is 49.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 113.83, based on 862 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Positron's current Market Cap of $57.87 Mil is 49.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Positron and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 113.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Positron's current Market Cap is $57.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Positron stock overvalued right now?
Based on GuruFocus' analysis, Positron (POSC) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.12, compared to a current price of $1.76 — trading 1368.3% above its estimated fair value. The current Market Cap is $57.87 Mil and 49.2% below the Medical Devices & Instruments industry median of 113.83. Positron's overall GF Score™ is 30/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Positron (POSC), the current Market Cap is $57.87 Mil as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Positron (POSC) Overvalued in 2026?
Based on GuruFocus' analysis, Positron stock appears to be overvalued.
The current stock price of $1.76 is trading 1368.3% above its estimated GF Value™ of $0.12.
GuruFocus considers Positron to be Significantly Overvalued.
Key valuation signals for POSC:
Market Cap: $57.87 Mil
GF Value™: $0.12 vs. price of $1.76 (1368.3% above fair value)
Industry Position: 49.2% below the Medical Devices & Instruments median (#516 of 862)
No single metric tells the full story. See the POSC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Positron Corp is a medical technology company engaged in the co-development, manufacture, and sale of PET and PET-CT imaging systems, delivering high-performance, cost-effective molecular imaging solutions that empower healthcare providers to improve the diagnosis and treatment of cardiovascular disease and other critical conditions. By combining proprietary PET and PET-CT systems with comprehensive clinical and technical support, flexible financing, & a focus on operational efficiency, Positron makes advance diagnostic imaging more accessible & sustainable for hospitals, outpatient centers, & physician practices. The company focused on advancing positron emission tomography imaging through the development, manufacture, & commercialization of PET & PET-computed tomography imaging systems.
30GF Score
Get the complete analysis for POSC
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
POSC has been successfully added to your 
